Table 2.
Movement-related modulations of beta subthalamic rhythms
| Low beta | High beta | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| b | p | m | r | b | P | m | r | ||
| AM (a.u.) | |||||||||
| Before levodopa | Mean | 0.74 | 0.74 | 0.71 | 0.84 | 0.37 | 0.29 | 0.21 | 0.44 |
| s.d. | 0.34 | 0.38 | 0.49 | 0.34 | 0.30 | 0.28 | 0.36 | 0.32 | |
| After levodopa | Mean | 0.42 | 0.38 | 0.33 | 0.51 | 0.31 | 0.24 | 0.13 | 0.36 |
| s.d. | 0.37 | 0.34 | 0.37 | 0.39 | 0.35 | 0.28 | 0.27 | 0.37 | |
| FM (Hz) | |||||||||
| Before levodopa | Mean | 17.11 | 17.18 | 17.45 | 16.89 | 26.43 | 26.49 | 26.59 | 25.95 |
| s.d. | 1.46 | 1.47 | 1.41 | 1.29 | 1.12 | 1.33 | 1.64 | 1.00 | |
| After levodopa | Mean | 17.07 | 17.1 | 16.68 | 17.06 | 26.55 | 26.68 | 26.81 | 26.48 |
| s.d. | 1.58 | 1.47 | 1.25 | 1.73 | 1.13 | 1.19 | 1.24 | 1.18 | |
The table reports means and standard deviations (s.d.) of the amplitude modulations (AM, in log power arbitrary units, a.u.) and the frequency modulations (FM, in Hz) for the low-beta and the high-beta poles, of all nuclei recorded before (n = 14) and after (n = 14 nuclei) levodopa administration. Entries for each nucleus were obtained by averaging the pole values of individual nuclei in four movement-related time windows: b= baseline (4 s to 2 s before movement onset), p= pre-movement (0.5 s to 0 s before movement onset), m= movement (0 s to 1 s after movement onset), r= recovery (2 s to 3 s after movement onset). The full movement-related AM/FM curves corresponding to this table are shown in Fig. 3.